Charles M Baum - Net Worth and Insider Trading
Charles M Baum Net Worth
The estimated net worth of Charles M Baum is at least $10 Million dollars as of 2024-11-13. Charles M Baum is the President,Founder,Head of R&D of Mirati Therapeutics Inc and owns about 168,777 shares of Mirati Therapeutics Inc (MRTX) stock worth over $10 Million. Charles M Baum is also the Director of Array BioPharma Inc and owns about 10,000 shares of Array BioPharma Inc (ARRY) stock worth over $389,500. Details can be seen in Charles M Baum's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles M Baum has not made any transactions after 2023-01-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Charles M Baum
Charles M Baum Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles M Baum owns 7 companies in total, including BCTG Acquisition Corp (BCTG) , Mirati Therapeutics Inc (MRTX) , and Immunomedics Inc (IMMU) among others .
Click here to see the complete history of Charles M Baum’s form 4 insider trades.
Insider Ownership Summary of Charles M Baum
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCTG | BCTG Acquisition Corp | 2020-09-02 | director |
| MRTX | Mirati Therapeutics Inc | 2023-01-04 | director & President & CEO |
| IMMU | Immunomedics Inc | 2020-10-23 | director |
 | | 2021-04-01 | director |
| | 2020-09-02 | director |
| | 2023-06-15 | director |
| | 2023-06-22 | director |
Charles M Baum Latest Holdings Summary
Charles M Baum currently owns a total of 2 stocks. Among these stocks, Charles M Baum owns 168,777 shares of Mirati Therapeutics Inc (MRTX) as of January 4, 2023, with a value of $10 Million and a weighting of 96.22%. Charles M Baum also owns 10,000 shares of Array BioPharma Inc (ARRY) as of February 9, 2018, with a value of $389,500 and a weighting of 3.78%.
Latest Holdings of Charles M Baum
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MRTX | Mirati Therapeutics Inc | 2023-01-04 | 168,777 | 58.70 | 9,907,210 |
| ARRY | Array BioPharma Inc | 2018-02-09 | 10,000 | 38.95 | 389,500 |
Holding Weightings of Charles M Baum
Charles M Baum Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles M Baum has made a total of 10 transactions in Mirati Therapeutics Inc (MRTX) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Mirati Therapeutics Inc is the sale of 3,648 shares on January 4, 2023, which brought Charles M Baum around $169,997.
According to the SEC Form 4 filings, Charles M Baum has made a total of 0 transactions in Array BioPharma Inc (ARRY) over the past 5 years. The most-recent trade in Array BioPharma Inc is the sale of 50,000 shares on February 9, 2018, which brought Charles M Baum around $845,000.
Insider Trading History of Charles M Baum
- 1
Charles M Baum Trading Performance
GuruFocus tracks the stock performance after each of Charles M Baum's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles M Baum is 6.98%. GuruFocus also compares Charles M Baum's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles M Baum within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles M Baum's insider trading performs compared to the benchmark.
Performance of Charles M Baum
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -16.04 | | | | | |
| Relative Return to S&P 500(%) | -19.26 | | | | | |
Charles M Baum Ownership Network
Ownership Network List of Charles M Baum
Ownership Network Relation of Charles M Baum
Charles M Baum Owned Company Details
What does BCTG Acquisition Corp do?
Who are the key executives at BCTG Acquisition Corp?
Charles M Baum is the director of BCTG Acquisition Corp. Other key executives at BCTG Acquisition Corp include 10 percent owner Bctg Holdings, Llc , director & Chief Executive Officer Aaron I. Davis , and director & President Christopher Fuglesang .
BCTG Acquisition Corp (BCTG) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of BCTG Acquisition Corp (BCTG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BCTG Acquisition Corp (BCTG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
BCTG Acquisition Corp (BCTG)'s detailed insider trading history can be found in Insider Trading Tracker table.
BCTG Acquisition Corp Insider Transactions
Charles M Baum Mailing Address
Above is the net worth, insider trading, and ownership report for Charles M Baum. You might contact Charles M Baum via mailing address: C/o Mirati Therapeutics Inc., 9393 Towne Centre Drive, Ste 200, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
